Category: Regulatory/FDA

Eye on FDA Data Analysis Shows Videos Are Cited Most for Risk Minimization, Overstatement of Efficacy

Forbes Article Shines New Light on “Academic” Detailing

OPDP Enforcement Webinar Slated for Oct. 29

Massachusetts to Hold Oct. 19 Public Hearing to Discuss “Modest Meal” Exception

OPDP's Sauers Uses Real-world Examples in “Drug Marketing Primer” Discussion

OPDP Issues Seven Enforcement Letters in May and June

Risk Communication Advisory Committee to Discuss Communicating Uncertainty, Multiple Risks

PhRMA, Industry Members Object to TV Ad Review Draft Guidance

FDA Looks to Consumers for Pre-approval Input